PAND insider filings

Pandion Therapeutics, Inc. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-04-01. Screen PAND transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for PAND between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Pandion Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2021-04-014Viney Joanne L. — See RemarksCode (U): 503,254 @ $60 · Code (U): 1,200 @ $60 · Disposition to issuer (D): 114,876 (derivative) · Disposition to issuer (D): 73,789 (derivative)EDGAR
2021-04-014Freedman Edward D. — Chief Operating OfficerCode (U): 54,460 @ $60 · Disposition to issuer (D): 55,903 (derivative) · Disposition to issuer (D): 36,895 (derivative)EDGAR
2021-04-014Kakkar Rahul — Chief Executive Officer, DirectorCode (U): 14,000 @ $60 · Code (U): 702,515 @ $60 · Disposition to issuer (D): 348,741 (derivative) · Disposition to issuer (D): 221,367 (derivative)EDGAR
2021-04-014Sundy John — Chief Medical OfficerCode (U): 115,826 @ $60 · Disposition to issuer (D): 145,420 (derivative) · Disposition to issuer (D): 73,789 (derivative)EDGAR
2021-04-014Stagliano Nancy — DirectorCode (U): 1,000 @ $60 · Code (U): 73,067 @ $60 · Disposition to issuer (D): 17,671 (derivative)EDGAR
2021-04-014Frail Donald — DirectorCode (U): 61,113 @ $60 · Disposition to issuer (D): 18,747 (derivative)EDGAR
2021-04-014Carlo Rizzuto — DirectorDisposition to issuer (D): 13,997 (derivative)EDGAR
2021-04-014Becker Daniel J. — DirectorCode (U): 1,000 @ $60 · Code (U): 2,827,883 @ $60 · Disposition to issuer (D): 13,997 (derivative)EDGAR
2021-04-014Goyal Vikas — See RemarksCode (U): 87,764 @ $60 · Disposition to issuer (D): 28,227 (derivative) · Disposition to issuer (D): 73,789 (derivative)EDGAR
2021-04-014Larson Eric D — Vice President, FinanceCode (U): 22,125 @ $60 · Disposition to issuer (D): 27,500 (derivative) · Disposition to issuer (D): 23,000 (derivative)EDGAR
2021-04-014Dorton Katina — DirectorDisposition to issuer (D): 27,994 (derivative)EDGAR
2021-04-014Carroll Jill — Director, 10% ownerCode (U): 5,674,221 @ $60 · Disposition to issuer (D): 13,997 (derivative)EDGAR
2021-04-014Fuglesang Christopher — Director, 10% ownerCode (U): 2,107,513 @ $60 · Code (U): 23,622 @ $60 · Disposition to issuer (D): 13,997 (derivative)EDGAR
2021-04-014Crane Alan L — Director, 10% ownerCode (U): 84,158 @ $60 · Code (U): 336,314 @ $60 · Code (U): 3,090,801 @ $60 · Code (U): 110,621 @ $60 · Disposition to issuer (D): 13,997 (derivative)EDGAR
2021-04-014BELOFF GREGG — See RemarksCode (U): 13,196 @ $60EDGAR
2021-02-104Kakkar Rahul — Chief Executive Officer, DirectorGrant/award (A): 221,367 (derivative) @ $0EDGAR
2021-02-104Freedman Edward D. — Chief Operating OfficerGrant/award (A): 36,895 (derivative) @ $0EDGAR
2021-02-104Viney Joanne L. — See RemarksGrant/award (A): 73,789 (derivative) @ $0EDGAR
2021-02-104Sundy John — Chief Medical OfficerGrant/award (A): 73,789 (derivative) @ $0EDGAR
2021-02-104Goyal Vikas — See RemarksGrant/award (A): 73,789 (derivative) @ $0EDGAR
2021-02-104Larson Eric D — Vice President, FinanceGrant/award (A): 23,000 (derivative) @ $0EDGAR
2020-12-044Dorton Katina — DirectorGrant/award (A): 27,994 (derivative) @ $0EDGAR
2020-11-234Becker Daniel J. — DirectorPurchase (P): 197,716 @ $15.12EDGAR
2020-11-194Becker Daniel J. — DirectorPurchase (P): 2,170 @ $14.63 · Purchase (P): 13,027 @ $15.43 · Purchase (P): 14,197 @ $15.26EDGAR

Recent 8-K events — Pandion Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-04-018-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-258-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-01-048-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2020-12-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2020-11-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-318-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PAND returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs